Interim Analysis of a Prospective Randomized Non-Inferiority Trial of Cisplatin and Fluorouracil Induction Chemotherapy With or Without Docetaxel in Nasopharyngeal Carcinoma

Oncotarget - United States
doi 10.18632/oncotarget.10903
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Docetaxel, Cisplatin and Fluorouracil (DCF) Regimen Compared With Non-Taxane-Containing Palliative Chemotherapy for Gastric Carcinoma: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2013English

Rate of Pathologic Complete Responses to Docetaxel, Cisplatin, and Fluorouracil Induction Chemotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck

Archives of Otolaryngology–Head & Neck Surgery
2006English

Neoadjuvant Docetaxel, Cisplatin and Fluorouracil Followed by Concurrent Cisplatin Intensity Modulated Radiation Therapy in Treatment of Locally Advanced Nasopharyngeal Carcinoma

Research in Oncology
2013English

A Pairwise Meta‐Analysis of Induction Chemotherapy in Nasopharyngeal Carcinoma

Oncologist
Cancer ResearchMedicineOncology
2019English

Cisplatin and Fluorouracil Alone or With Docetaxel in Head and Neck Cancer

New England Journal of Medicine
Medicine
2007English

RAB37 Hypermethylation Regulates Metastasis and Resistance to Docetaxel-Based Induction Chemotherapy in Nasopharyngeal Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2018English

5-Fluorouracil Combined With Cisplatin via Arterial Induction for Advanced T-Stage Nasopharyngeal Carcinoma: A 10-Year Outcome Study

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Induction With Mitomycin C, Doxorubicin, Cisplatin and Maintenance With Weekly 5-Fluorouracil, Leucovorin for Treatment of Metastatic Nasopharyngeal Carcinoma: A Phase II Study

British Journal of Cancer
Cancer ResearchOncology
1999English

Phase II, Multicenter, Randomized Trial of Docetaxel Plus Prednisone With or Without Cediranib in Men With Chemotherapy‐Naive Metastatic Castrate‐Resistant Prostate Cancer

Oncologist
Cancer ResearchMedicineOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy